Explain this page
Arphra AIPlain-English read on ConocoPhillips’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +31.98% | +37.70% | +31.77% | +29.35% | +24.63% | +28.39% | +29.25% | +27.91% | +27.89% |
| Operating margin | +26.87% | +32.63% | +26.81% | +23.41% | +19.58% | +23.65% | +22.99% | +23.29% | +22.99% |
| EBITDA margin | +45.79% | +47.25% | +46.00% | +44.72% | +39.47% | +42.61% | +43.01% | +42.47% | +42.64% |
| EBIT margin | +30.05% | +37.26% | +30.95% | +27.06% | +19.58% | +25.41% | +26.38% | +26.17% | +25.15% |
| Pre-tax margin | +27.60% | +35.92% | +29.06% | +25.03% | +21.56% | +25.14% | +25.15% | +25.12% | +25.19% |
| Net margin | +17.54% | +23.69% | +19.48% | +16.88% | +13.60% | +16.45% | +17.02% | +16.17% | +16.57% |
| Cost structure | |||||||||
| Cost of revenue / sales | +68.02% | +62.30% | +68.23% | +70.65% | +75.37% | +70.60% | +70.41% | +69.45% | +70.09% |
| R&D intensity | +0.13% | +0.09% | +0.14% | +0.15% | +0.13% | +0.14% | +0.14% | +0.14% | +0.14% |
| SG&A intensity | +1.76% | +1.35% | +1.11% | +1.97% | +1.27% | +1.47% | +1.44% | +1.42% | +1.46% |
| Effective tax rate | +36.45% | +33.82% | +32.73% | +32.38% | +36.88% | +34.71% | +34.26% | +34.62% | +33.63% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +17.79% | +38.79% | +22.16% | +14.23% | +12.39% | +15.23% | +15.79% | +15.79% | +15.78% |
| Return on assets (ROA) | +8.91% | +19.84% | +11.39% | +7.51% | +6.55% | +8.31% | +8.59% | +8.07% | +8.04% |
| Return on capital (ROC) | +18.94% | +39.33% | +21.81% | +14.18% | +13.07% | +15.84% | +15.52% | +16.36% | +15.82% |
| Return on invested capital (ROIC) | +12.36% | +28.56% | +15.85% | +10.23% | +9.08% | +11.02% | +11.49% | +11.35% | +11.40% |
| Asset turnover | +50.80% | +83.75% | +58.44% | +44.48% | +48.15% | +50.51% | +50.47% | +49.89% | +48.56% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +17.54% | +23.69% | +19.48% | +16.88% | +13.60% | +16.45% | +17.02% | +16.17% | +16.57% |
| Asset turnover (× revenue / assets) | +50.80% | +83.75% | +58.44% | +44.48% | +48.15% | +50.51% | +50.47% | +49.89% | +48.56% |
| Equity multiplier (× assets / equity) | +199.67% | +195.46% | +194.65% | +189.49% | +189.09% | +183.27% | +183.88% | +195.75% | +196.11% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.51 | 0.84 | 0.58 | 0.44 | 0.48 | 0.51 | 0.50 | 0.50 | 0.49 |
| Fixed-asset turnover | 0.71 | 1.20 | 0.79 | 0.57 | 0.63 | — | — | — | — |
| Inventory turnover | 25.93 | 40.16 | 27.36 | 21.33 | 23.63 | — | — | — | — |
| Receivables turnover | 6.90 | 11.09 | 10.24 | 8.16 | 10.10 | — | — | — | — |
| Payables turnover | 6.23 | 7.94 | 7.47 | 6.38 | 7.12 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 52.86 | 32.92 | 35.64 | 44.75 | 36.14 | — | — | — | — |
| Days inventory outstanding (DIO) | 14.07 | 9.09 | 13.34 | 17.11 | 15.45 | — | — | — | — |
| Days payables outstanding (DPO) | 58.54 | 45.95 | 48.83 | 57.18 | 51.29 | — | — | — | — |
| Cash conversion cycle | 8.39 | -3.94 | 0.15 | 4.68 | 0.30 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 2.10 | 1.52 | 1.83 | 2.18 | 2.48 | 2.15 | 2.11 | 2.18 | 2.17 |
| FCF / Net income | 1.44 | 0.98 | 0.80 | 0.87 | 2.10 | 1.21 | 1.15 | 1.21 | 1.15 |
| FCF margin | +25.34% | +23.10% | +15.55% | +14.66% | +28.57% | +19.91% | +19.50% | +19.50% | +19.05% |
| OCF margin | +36.90% | +36.03% | +35.62% | +36.85% | +33.72% | +35.44% | +35.91% | +35.32% | +35.88% |
| CapEx / Revenue | +11.56% | +12.93% | +20.07% | +22.19% | +5.15% | +15.91% | +16.24% | +15.91% | +16.22% |
| CapEx / D&A | 0.74 | 1.35 | 1.36 | 1.26 | 0.26 | — | — | — | — |
| Stock-based comp / Revenue | +0.66% | +0.48% | 0.00% | 0.00% | 0.00% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 6.08 | 14.57 | 9.06 | 7.81 | 6.35 | 10.15 | 9.00 | 9.10 | 10.93 |
| EPS · basic | 6.10 | 14.62 | 9.08 | 7.82 | 6.36 | 10.05 | 9.15 | 9.21 | 10.91 |
| Book value / share | 34.19 | 37.56 | 40.87 | 54.87 | 51.45 | 60.60 | 55.74 | 55.13 | 59.82 |
| Tangible BV / share | 34.19 | 37.56 | 40.87 | 54.87 | 51.45 | 60.60 | 55.74 | 55.13 | 59.82 |
| Sales / share | 34.68 | 61.48 | 46.49 | 46.25 | 46.84 | 56.09 | 51.73 | 53.84 | 56.96 |
| Operating CF / share | 12.80 | 22.15 | 16.56 | 17.04 | 15.79 | 19.88 | 18.58 | 19.02 | 20.44 |
| Free cash flow / share | 8.79 | 14.20 | 7.23 | 6.78 | 13.38 | 11.17 | 10.09 | 10.50 | 10.85 |
| Dividends / share | 1.78 | 4.48 | 4.63 | 3.09 | 3.19 | 4.49 | 3.92 | 4.08 | 4.40 |
| Payout ratio | +29.20% | +30.75% | +51.12% | +39.55% | +50.01% | +48.66% | +44.54% | +46.91% | +46.66% |
| Retention ratio | +70.80% | +69.25% | +48.88% | +60.45% | +49.99% | +51.34% | +55.46% | +53.09% | +53.34% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +70.62% | -28.67% | -2.57% | +7.51% | +20.17% | -7.28% | +2.16% | +7.82% | +5.76% |
| Gross profit · YoY | — | +101.18% | -39.89% | -10.00% | -9.77% | +38.53% | -4.50% | -2.51% | +7.75% | +3.96% |
| Profit | ||||||||||
| Operating income · YoY | — | +107.22% | -41.38% | -14.95% | -10.08% | +45.19% | -9.89% | +3.52% | +6.40% | +3.71% |
| EBITDA · YoY | — | +76.04% | -30.55% | -5.27% | -5.11% | +29.71% | -6.40% | +0.88% | +8.25% | +4.82% |
| Net income · YoY | — | +130.47% | -41.34% | -15.60% | -13.34% | +45.32% | -4.09% | -2.94% | +10.47% | +5.00% |
| Operating | ||||||||||
| EBIT · YoY | — | +111.61% | -40.75% | -14.82% | -22.23% | +55.98% | -3.74% | +1.36% | +3.63% | +3.43% |
| R&D · YoY | — | +14.52% | +14.08% | 0.00% | -3.70% | +24.83% | -5.60% | +3.47% | +7.83% | +6.49% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +139.64% | -37.82% | -13.80% | -18.69% | +59.76% | -11.27% | +1.09% | +20.09% | +7.60% |
| EPS · basic · YoY | — | +139.67% | -37.89% | -13.88% | -18.67% | +57.98% | -8.91% | +0.66% | +18.41% | +7.54% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $19.93B | $17.19B | $19.63B | $25.35B | $23.44B | $29.14B | $26.39B | $26.74B | $29.01B |
| Net debt | $14.91B | $10.73B | $14B | $19.74B | $16.95B | $21.65B | $19.52B | $19.66B | $21.67B |
| Net debt / EBITDA | 0.71 | 0.29 | 0.54 | 0.81 | 0.73 | 0.72 | 0.69 | 0.69 | 0.71 |
| Debt / equity | 0.44 | 0.36 | 0.40 | 0.39 | 0.36 | 0.38 | 0.37 | 0.39 | 0.38 |
| Debt / assets | +21.99% | +18.32% | +20.47% | +20.65% | +19.23% | +20.86% | +20.36% | +19.96% | +19.55% |
| Equity / assets | +50.08% | +51.16% | +51.37% | +52.77% | +52.88% | +54.57% | +54.38% | +51.09% | +50.99% |
| Coverage | |||||||||
| EBITDA / interest expense | 18.73 | 35.19 | 24.25 | 22.04 | 18.80 | 20.68 | 22.03 | 20.94 | 21.60 |
| Operating income / interest | 10.99 | 24.30 | 14.14 | 11.54 | 9.32 | 11.48 | 11.77 | 11.49 | 11.64 |
| Interest expense | $1.13B | $1.06B | $1.06B | $1.11B | $1.23B | $1.45B | $1.28B | $1.36B | $1.42B |
| Liquidity | |||||||||
| Current ratio | 1.34 | 1.46 | 1.43 | 1.29 | 1.30 | — | — | — | — |
| Quick ratio | 1.10 | 1.27 | 1.21 | 1.06 | 1.07 | — | — | — | — |
| Cash ratio | 0.42 | 0.50 | 0.56 | 0.46 | 0.54 | — | — | — | — |
| Working capital | $4.03B | $5.9B | $4.33B | $3.52B | $3.56B | — | — | — | — |
| Working capital / revenue | +8.75% | +7.51% | +7.72% | +6.45% | +6.06% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).